General Information of Drug (ID: DM9GOT6)

Drug Name
MGBG Drug Info
Synonyms
MITOGUAZONE; Methyl-Gag; 459-86-9; Methylglyoxal bis(guanylhydrazone); Me-GAG; Methylglyoxal bis(amidinohydrazone); Methyl-G; C5H12N8; Pyruvaldehyde bis(amidinohydrazone); Mitoguazonum; Mitoguazona; CHEMBL216913; CHEBI:43996; Methyl GAG; Mitoguazone [INN:DCF]; Mitoguazonum [INN-Latin]; MGGH; Mitoguazona [INN-Spanish]; (2E,2'E)-2,2'-(1E,2E)-propane-1,2-diylidenedihydrazinecarboximidamide; BRN 1912590; 2-[(E)-[(1E)-1-(diaminomethylidenehydrazinylidene)propan-2-ylidene]amino]guanidine
Indication
Disease Entry ICD 11 Status REF
Head and neck cancer 2D42 Terminated [1]
Cross-matching ID
PubChem CID
5351154
ChEBI ID
CHEBI:43996
CAS Number
CAS 459-86-9
TTD Drug ID
DM9GOT6

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Discontinued Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tromethamine DMOBLGK Acidosis 5C73 Approved [3]
ORG 34517/34850 DMR3P98 Mood disorder 6A60-6E23 Phase 2 [2]
Putrescine DMWE6V1 Burn and burn infection ND90-NE2Z Discontinued in Phase 2 [3]
CGP-40215A DM69YWS Pneumocystis pneumonia CA40.20 Terminated [4]
5'-deoxy-5'-[(3-hydrazinopropyl)methylamino]adenosine DM6HGUL Discovery agent N.A. Investigative [1]
5'-Deoxy-5'-(N,N-dimethylamino)adenosine DMF7JPO Discovery agent N.A. Investigative [5]
Hydroxyalanine DM5HWZY Discovery agent N.A. Investigative [6]
5'-Deoxy-5'-dimethylsulfonioadenosine chloride DM1NAMK Discovery agent N.A. Investigative [5]
[(2-aminooxyethyl)methylamino]-5'-deoxyadenosine DM3WDOY Discovery agent N.A. Investigative [5]
5'-([(Z)-4-amino-2-butenyl]methylamino)-5'-deoxyadenosine DMT6D5V Discovery agent N.A. Investigative [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
S-adenosylmethionine decarboxylase proenzyme (AMD1) TTBFROQ DCAM_HUMAN Inhibitor [2]

References

1 S-adenosylmethionine decarboxylase as an enzyme target for therapy. Pharmacol Ther. 1992 Dec;56(3):359-77.
2 A phase I study of a new polyamine biosynthesis inhibitor, SAM486A, in cancer patients with solid tumours. Br J Cancer. 2000 Sep;83(5):594-601.
3 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
4 Antileishmanial effect of a potent S-adenosylmethionine decarboxylase inhibitor: CGP 40215A. Pharmacol Res. 1996 Jan;33(1):67-70.
5 New insights into the design of inhibitors of human S-adenosylmethionine decarboxylase: studies of adenine C8 substitution in structural analogues ... J Med Chem. 2009 Mar 12;52(5):1388-407.
6 DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-41.